A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression

NCT06259526 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: Placebo group
DRUG: JS1-1-01 low-dose group
DRUG: JS1-1-01 pills; JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules
DRUG: JS1-1-01 high-dose group
DRUG: Active drug group

Sponsor

Tasly Pharmaceutical Group Co., Ltd